Etiometry
Boston, US · Delaware corporation · 1 known investors
Etiometry develops a clinical decision support platform that uses continuous streams of physiologic data to quantify clinical risks for patients in hospital critical care and intensive care units. The company applies AI-based predictive analytics to support clinicians managing critically ill patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Founders & leadership
EB
Evan ButlerChief Operating Officer and Co-Founder
DB
Dimitar BaronovChief Technology Officer and Co-Founder
PR
Peter RockChief Financial Officer
JL
Jesse LockChief Medical Officer
EM
Eric MeyersNamed on SEC filing
NS
Nelson StacksNamed on SEC filing
SC
Shane CookePresident & Chief Executive Officer
HB
Howard BrickChief Strategy Officer
BR
Brad RosenblumChief Financial Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 3 rounds · 2017–2022
▶$10MraisedApr 2024 · 7 investors · Other Health CareRule 506(b)
▶$10MraisedApr 2024 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David ShepherdDirector
- Evan ButlerExecutive Officer, Director
- Gregory S. MartinDirector
- Guy Lyndon FishDirector
- Shane CookeExecutive Officer, Director
- Dimitar BaronovExecutive Officer
- Brad RosenblumExecutive Officer
- Offering amount
- $14M
- Amount sold
- $10M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedMar 2021 · 24 investors · Other Health CareRule 506(b)
▶$5.1MraisedMar 2021 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bradley RosenblumExecutive Officer
- Evan ButlerExecutive Officer, Director
- Shane CookeExecutive Officer, Director
- Guy Lyndon FishDirector
- Gregory S. MartinDirector
- David ShepherdDirector
- Dimitar BaronovExecutive Officer
- Offering amount
- $9M
- Amount sold
- $5.1M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedOct 2017 · 3 investors · Other Health CareRule 506(b)
▶$500KraisedOct 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evan ButlerExecutive Officer, Director
- Eric MeyersDirector
- Nelson StacksDirector
- Dimitar BaronovExecutive Officer, Director
- Peter RockExecutive Officer, Director
- Jesse LockExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $500K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlaptrusted97 shared keywordsTrusted Health operates a platform for healthcare clinicians to build a digital resume, browse and apply to jobs, receive match alerts, and accept offers, along with onboarding support, weekly pay, benefits, and 24/7 assistance. It serves nurses and other clinical professionals seeking healthcare staffing positions.
ShiftMed77 shared keywordsShiftMed operates an on-demand healthcare staffing platform that connects hospitals, health systems, and long-term care facilities with credentialed nurses (CNAs, LPNs, RNs) to fill shifts and manage their workforce. It integrates via API with workforce management systems and offers worker benefits such as transportation, insurance, and education.
Nursa70 shared keywordsNursa operates a marketplace platform that connects healthcare facilities with nurses and nursing assistants to fill per diem shifts on demand.
Companies competing with Etiometry for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $300.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $498.2K |
| Department of DefenseDefense Health Program | Phase I | 2011 | $149.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $99.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Etiometry do?
- Etiometry develops a clinical decision support platform that uses continuous streams of physiologic data to quantify clinical risks for patients in hospital critical care and intensive care units. The company applies AI-based predictive analytics to support clinicians managing critically ill patients.
- Who founded Etiometry?
- Etiometry was founded by Evan Butler, Dimitar Baronov.
- Who are Etiometry's investors?
- Etiometry's investors include Escalate Capital Partners.
- How much funding has Etiometry raised?
- Etiometry has disclosed $15.6M raised across 3 rounds.
- Where is Etiometry headquartered?
- Etiometry is headquartered in Boston, US.